Advanced in Chronic Myelomonocytic Leukemia (CMML)

Johanna S. Ungerstedt

Linkoeping, E, SE 
Advanced in Chronic Myelomonocytic Leukemia (CMML)
Linkoeping, E, SE 
OverviewLocationsClinical Research

Overview

Johanna Ungerstedt practices in Linkoeping, Sweden. Ms. Ungerstedt is rated as an Advanced expert by MediFind in the treatment of Chronic Myelomonocytic Leukemia (CMML). Her top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Chronic Myelomonocytic Leukemia (CMML), and Myelodysplastic Syndrome (MDS).

Her clinical research consists of co-authoring 41 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Chronic Myelomonocytic Leukemia (CMML).

Gender
Female

Locations

Linkoeping, E, Sweden
Other Locations
Huddinge, AB, Sweden
Stockholm, AB, Sweden
Solna, AB, Sweden
S 14186, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy
Enrollment Status: Active_not_recruiting
Publish Date: September 23, 2025
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 2

41 Total Publications

Title Not Found
Title Not Found
Journal: Lakartidningen
Published: August 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ungerstedt's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile